Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4436608
Max Phase: Preclinical
Molecular Formula: C14H18O3S
Molecular Weight: 266.36
Molecule Type: Unknown
Associated Items:
ID: ALA4436608
Max Phase: Preclinical
Molecular Formula: C14H18O3S
Molecular Weight: 266.36
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C/C(C)=C/[C@@]1(C)SC(=O)C(C(=O)CCC)=C1O
Standard InChI: InChI=1S/C14H18O3S/c1-5-7-10(15)11-12(16)14(4,18-13(11)17)8-9(3)6-2/h6,8,16H,2,5,7H2,1,3-4H3/b9-8+/t14-/m1/s1
Standard InChI Key: LPESGLORWPLCBU-MYSGNRETSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 266.36 | Molecular Weight (Monoisotopic): 266.0977 | AlogP: 3.33 | #Rotatable Bonds: 5 |
Polar Surface Area: 54.37 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.97 | CX Basic pKa: | CX LogP: 3.21 | CX LogD: -0.31 |
Aromatic Rings: 0 | Heavy Atoms: 18 | QED Weighted: 0.61 | Np Likeness Score: 1.58 |
1. Bommineni GR, Kapilashrami K, Cummings JE, Lu Y, Knudson SE, Gu C, Walker SG, Slayden RA, Tonge PJ.. (2016) Thiolactomycin-Based Inhibitors of Bacterial β-Ketoacyl-ACP Synthases with in Vivo Activity., 59 (11): [PMID:27187871] [10.1021/acs.jmedchem.6b00236] |
Source(1):